NASDAQ:CMRAW

Comera Life Sciences (CMRAW) Stock Price, News & Analysis

$0.0008
0.00 (0.00%)
(As of 05/2/2024 ET)
Today's Range
$0.0008
$0.0008
50-Day Range
N/A
52-Week Range
$0.00
$0.06
Volume
N/A
Average Volume
43,247 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Comera Life Sciences

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

CMRAW Stock Price History

CMRAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive CMRAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CMRAW
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.00 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Michael G. Campbell CPA (Age 55)
    CEO, CFO & Principal Accounting Officer
    Comp: $269.11k
  • Dr. David Soane Ph.D.
    Co-Founder & Member of Scientific Advisory Board
  • Ms. Janice Marie McCourt B.S. (Age 62)
    CLP, M.B.A., R.Ph., Chief Business Officer

CMRAW Stock Analysis - Frequently Asked Questions

How have CMRAW shares performed in 2024?

Comera Life Sciences' stock was trading at $0.0030 at the beginning of 2024. Since then, CMRAW shares have decreased by 73.3% and is now trading at $0.0008.
View the best growth stocks for 2024 here
.

How do I buy shares of Comera Life Sciences?

Shares of CMRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CMRAW) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners